Loading…
Hosted by Unknown Host · 🇺🇸 US · EN
Established thought leaders with verified media credentials.
A Cleveland Clinic podcast for medical professionals exploring the latest innovative research and clinical advances in the field of oncology.
Unknown Host hosts Cleveland Clinic Cancer Advances.
As new therapies move through clinical trials, the management of uveal melanoma is entering a period of significant change. In this episode of Cancer Advances, Arun Singh, MD, discusses emerging strategies to avoid radia
How can oncologists initiate meaningful goals-of-care discussions earlier in the disease course? In this episode, Dr. Natalie Jacobowski outlines practical communication strategies, including language, timing and approac
How can better data improve decision-making in a curable but nuanced disease like testicular cancer? This episode explores how large language models can turn unstructured clinical notes into actionable insights, helping
Is there a role for earlier integration of lutetium PSMA therapy in mCRPC management? Emerging evidence supports its use in the pre-taxane setting, prompting a shift in sequencing decisions. This episode outlines patient
As cancer care becomes increasingly personalized, treatment deescalation is emerging as a key strategy to balance efficacy with quality of life. In this episode of Cancer Advances, Jame Abraham, MD, Enterprise Chair of H
How can we better predict progression and outcomes in a disease where treatment decisions must be made in days, sometimes hours? In this episode of Cancer Advances, Moaath Mustafa Ali, MD, MPH, discusses emerging longitu
Young patients requiring pelvic radiation face limited fertility preservation options. In this episode of Cancer Advances, Robert DeBernardo, MD, and Johanna Kelley, MD, both gynecologic oncologists at Cleveland Clinic,
Shilpa Gupta, MD, Genitourinary Medical Oncologist, joins the Cancer Advances podcast to explore how perioperative immunotherapy and ctDNA are redefining management of muscle-invasive bladder cancer. She reviews emerging
Lilyana Angelov, MD, Neurosurgeon and Director of the Cleveland Clinic Gamma Knife Center, Samuel Chao, MD, Radiation Oncologist and Associate Director of the Gamma Knife Center; and Ajit Krishnaney, MD, Neurosurgeon in
Amy Smith, MD, Pediatric Neuro-Oncologist, joins the Cancer Advances podcast to discuss recent progress in pediatric neuro-oncology. Listen as Dr. Smith explains the advances in tumor biology that are shaping treatment d
Brian Barnett, MD, Director of the Cleveland Clinic Psychiatric Treatment Resistance Program, joins the Cancer Advances podcast to discuss adjustment disorder in patients with cancer. Dr. Barnett shares how oncologists c
Thuy Nguyen, DAOM, LAc, Section Head of Acupuncture for the Wellness ad Preventive Medicine Department at Cleveland Clinic, joins the Cancer Advances podcast discuss how acupuncture is being integrated into cancer care.
Director of the Inpatient Leukemia Unit, Anjali Advani, MD joins the Cancer Advances podcast to break down the latest acute myeloid leukemia clinical trials. From venetoclax-based regimens to emerging menin inhibitors an
Could removing heat improve safety in endoscopic mucosal resection? Florida Division Chair of the Department of Gastroenterology, Hepatology and Nutrition, and the Florida Region Director for Endoscopy, Tolga Erim, DO, j
Mina Lobbous, MD, MSPH, Neuro-Oncologist and Medical Director of the Adult Neurofibromatosis and Schwannomatosis Clinic at Cleveland Clinic, joins the Cancer Advances podcast to talk about the landscape of neurofibromato
The Cancer Advances Podcast welcomes back Nathan Mesko, MD, Vice Chair of Global Clinical Operations for the Department of Orthopaedic Surgery and Center Director for Musculoskeletal Oncology at Cleveland Clinic to talk
Bethany Samuelson Bannow, MD, Director of Classical Hematology at Cleveland Clinic, joins the Cancer Advances podcast to discuss the evolving field of classical hematology and what it means for managing complex non-malig
Julie Lang, MD, Breast Surgical Oncologist, joins the Cancer Advances podcast to discuss advancing care for patients with inflammatory breast cancer. Listen as Dr. Lang outlines key clinical features that distinguish IBC
Associate Staff and Physician Scientist at Cleveland Clinic Children’s, Richa Sharma, MD, joins the Cancer Advances podcast to discuss the launch of a National DNA Repair and Telomere Biology Disorder Tumor Board. Listen
Radiation Oncologist and Physician Scientist Jacob Scott, MD, DPhil, joins the Cancer Advances podcast to discuss how chemograms may change the way oncologists select chemotherapy using transcriptomic data and predictive
Sponsor detection runs nightly. Check back soon.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Cleveland Clinic Cancer Advances has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their health audience.
Cleveland Clinic Cancer Advances is hosted by Unknown Host. The show is categorised under Health (fitness) and has published 0 episodes.
Cleveland Clinic Cancer Advances regularly covers Health, Fitness. It sits in the Health category, with a fitness focus.
Cleveland Clinic Cancer Advances is accessible for guests with genuine health expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
Cleveland Clinic Cancer Advances hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of Cleveland Clinic Cancer Advances average 19 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates Cleveland Clinic Cancer Advances's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched 5 days ago.